WallStSmart

The Ensign Group Inc (ENSG)vsMednax Inc (MD)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

The Ensign Group Inc generates 184% more annual revenue ($5.49B vs $1.93B). MD leads profitability with a 9.0% profit margin vs 6.9%. MD appears more attractively valued with a PEG of 0.24. MD earns a higher WallStSmart Score of 67/100 (B-).

ENSG

Buy

60

out of 100

Grade: C+

Growth: 8.0Profit: 6.0Value: 4.0Quality: 6.0
Piotroski: 4/9Altman Z: 2.15

MD

Strong Buy

67

out of 100

Grade: B-

Growth: 5.3Profit: 6.5Value: 9.3Quality: 5.5
Piotroski: 5/9Altman Z: 1.71
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ENSGSignificantly Overvalued (-39.8%)

Margin of Safety

-39.8%

Fair Value

$151.60

Current Price

$182.97

$31.37 premium

UndervaluedFair: $151.60Overvalued
MDUndervalued (+64.6%)

Margin of Safety

+64.6%

Fair Value

$60.68

Current Price

$27.08

$33.60 discount

UndervaluedFair: $60.68Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ENSG1 strengths · Avg: 8.0/10
Revenue GrowthGrowth
17.3%8/10

17.3% revenue growth

MD4 strengths · Avg: 9.0/10
PEG RatioValuation
0.2410/10

Growing faster than its price suggests

EPS GrowthGrowth
50.0%10/10

Earnings expanding 50.0% YoY

P/E RatioValuation
12.7x8/10

Attractively priced relative to earnings

Price/BookValuation
2.5x8/10

Reasonable price relative to book value

Areas to Watch

ENSG3 concerns · Avg: 3.7/10
PEG RatioValuation
1.544/10

Expensive relative to growth rate

P/E RatioValuation
27.9x4/10

Moderate valuation

Profit MarginProfitability
6.9%3/10

6.9% margin — thin

MD3 concerns · Avg: 3.3/10
Revenue GrowthGrowth
3.9%4/10

3.9% revenue growth

Altman Z-ScoreHealth
1.714/10

Distress zone — elevated risk

Free Cash FlowQuality
$-135.75M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : ENSG

The strongest argument for ENSG centers on Revenue Growth. Revenue growth of 17.3% demonstrates continued momentum.

Bull Case : MD

The strongest argument for MD centers on PEG Ratio, EPS Growth, P/E Ratio. PEG of 0.24 suggests the stock is reasonably priced for its growth.

Bear Case : ENSG

The primary concerns for ENSG are PEG Ratio, P/E Ratio, Profit Margin.

Bear Case : MD

The primary concerns for MD are Revenue Growth, Altman Z-Score, Free Cash Flow.

Key Dynamics to Monitor

ENSG profiles as a growth stock while MD is a value play — different risk/reward profiles.

ENSG carries more volatility with a beta of 0.69 — expect wider price swings.

ENSG is growing revenue faster at 17.3% — sustainability is the question.

ENSG generates stronger free cash flow (119M), providing more financial flexibility.

Bottom Line

MD scores higher overall (67/100 vs 60/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

The Ensign Group Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company is headquartered in San Juan Capistrano, California.

Mednax Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

MEDNAX, Inc., provides neonatal, maternal-fetal, pediatric cardiology, and other pediatric subspecialties in the United States and Puerto Rico. The company is headquartered in Sunrise, Florida.

Visit Website →

Want to dig deeper into these stocks?